Encyclopedia of Biostatistics 2005
DOI: 10.1002/0470011815.b2a01025
|View full text |Cite
|
Sign up to set email alerts
|

Factorial Designs in Clinical Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 24 publications
0
4
0
Order By: Relevance
“…Table presents secondary factorial analyses for the four antibiotic groups, considering either the dose or the duration. This type of analysis allows the evaluation of different experimental factors at the same time, providing that there is no interaction between them (Piantadosi, ). As no interaction between time of antibiotic intake and MTZ dose was determined by two‐way ANOVA (Appendix Table), the main effects of dose and treatment interval were tested at once (Table ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Table presents secondary factorial analyses for the four antibiotic groups, considering either the dose or the duration. This type of analysis allows the evaluation of different experimental factors at the same time, providing that there is no interaction between them (Piantadosi, ). As no interaction between time of antibiotic intake and MTZ dose was determined by two‐way ANOVA (Appendix Table), the main effects of dose and treatment interval were tested at once (Table ).…”
Section: Resultsmentioning
confidence: 99%
“…Table 4 presents secondary factorial analyses for the four antibiotic groups, considering either the dose or the duration. This type of analysis allows the evaluation of different experimental factors at the same time, providing that there is no interaction between them (Piantadosi, 2008).…”
Section: Secondary Outcomesmentioning
confidence: 99%
“…A major reason for conducting studies with a factorial design is to test whether or not treatments interact with each other (Piantadosi ). The test of interaction between therapies (cross products) for 24‐month CAL gain and PPD reduction revealed no statistical significance.…”
Section: Discussionmentioning
confidence: 99%
“…Randomized crossover trials, clinical experiments in which participants are assigned randomly to a sequence of treatments and each participant serves as one's own control in estimating treatment effect (Senn, 2002;Piantadosi, 2005), will be used in the present study. Participants will be assigned randomly to either rhythm training followed by cognitive training or cognitive training followed by rhythm training (Figure 1).…”
Section: Methodsmentioning
confidence: 99%